1. Guidance for industry: good reprint practices for the distribution of medical journal articles and medical or scientific reference publications on unapproved new uses of approved drugs and approved or cleared medical devices (draft guidelines) http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0053-gdl.pdf
2. Physicians' liability for off-label prescriptions;Riley;Nephrol News Issues,2007
3. Off-label prescribing among office-based physicians;Radley;Arch Intern Med,2006
4. Off-label prescribing: A call for heightened professional and government oversight;Dresser;J Law Med Ethics,2009
5. Combating antimicrobial resistance: policy recommendations to save lives;Spellberg;Clin Infect Dis,2011